Enzyme Inhibitors Market: By Industry, By Application & By Region - Forecast 2016-2021

  • ID: 3973973
  • Report
  • 158 pages
  • IndustryARC
1 of 3
Enzyme Inhibitors is a molecule which acts by binding to an enzyme reversibly or irreversibly and decreasing or completely inhibiting its catalytic activity. Enzyme inhibitors are made up of protein and they occur naturally. Since blocking an enzyme's activity alter a biochemical process and cause imbalance which may terminate and/or slow down a process. Enzymes are involved in metabolism they regulate various metabolic pathways. In insects and some animals natural enzyme inhibitors are produced and are used as defense system against predators. Majority of drugs to treat a number of chronic and/or life-threatening diseases are developed with a mechanism of action directed towards enzyme inhibition. Enzyme specificity and potency are the important factors considered while developing a drug. A high specificity and potency ensures that a drug will have few side effects and strong therapeutic effect. Also, enzyme inhibitors are used as diagnostic agent to screen various diseases.

Factors driving global demand for Enzyme Inhibitors are its wide applications in pharmaceutical, agrochemical industries. Restraining factors for enzyme inhibitor market is patent expiry of various drugs.

This report provides information on enzyme inhibitors market size for the year 2014-2016, and forecast of the same for year 2021. It also focuses on market drivers, challenges, restraints, market dynamics, growth indicators, competitive landscape, potential growth opportunities and other key aspects with respect to enzyme inhibitors market.

The market for enzyme inhibitors is expanding with the rising incidence of enzyme based diseases and increasing research and development activities. In developed countries like US, Europe the market growth for enzyme inhibitor is high because of better diagnosis rate for the diseases, availability of medical facility, infrastructure, awareness and available treatment options. In Asia pacific region Japan, china and India are most potential markets due to economic development, improvement in medical facilities and growing population.

This report identifies global enzyme inhibitor market on the basis of application and regional market as follows:
Enzyme inhibitor market is segmented based on application. In drug development, as a diagnostic agent and to synthesize pesticides
This report is further segmented based on potential markets for enzyme inhibitors. A detailed analysis by region – North America, Europe, Asia Pacific (APAC) and Rest of the World (RoW), has been provided in this report
This report looks into all the major companies operating in the enzyme inhibitor market. Some of the major companies’ profiles are as follows:
Ranbaxy Laboratories Ltd
Please Note: The report is to be delivered in 1-2 working days after an order is placed.
Note: Product cover images may vary from those shown
2 of 3
1. Enzyme Inhibitors – Market Overview

2. Executive Summary

3. Enzyme Inhibitors Market - Market Landscape
3.1. Market Share Analysis
3.2. Comparative Analysis
3.2.1. Product Benchmarking
3.2.2. End User Profiling
3.2.3. Top 5 Financials Analysis

4. Enzyme Inhibitors Market- Market Forces
4.1. Drivers
4.1.1. Increased focus on R&D
4.2. Restraints
4.2.1. Patent expiry of major drugs
4.3. Opportunities
4.4. Challenges
4.5. Porter’s Five Force Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Customers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Degree of Competition

5. Enzyme Inhibitors Market – Strategic Analysis
5.1. Value Chain Analysis
5.2. Pricing Analysis
5.3. Opportunities Analysis
5.4. Product/Market Life Cycle Analysis
5.5. Suppliers and Distributors

6. Enzyme Inhibitors Market, By application
6.1. Pharmaceutical Industry
6.2. Agrochemical Industry

7. Enzyme Inhibitors Market, By Geography
7.1. Introduction
7.2. North America
7.2.1. US
7.2.2. Canada
7.2.3. Mexico
7.3. Europe
7.3.1. U.K.
7.3.2. France
7.3.3. Germany
7.3.4. Italy
7.3.5. Spain
7.3.6. Rest of Europe
7.4. Asia Pacific
7.4.1. China
7.4.2. South Korea
7.4.3. Japan
7.4.4. India
7.4.5. Rest of Asia Pacific
7.5. RoW

8. Market Entropy
8.1. Expansion
8.2. Technological Developments
8.3. Merger & Acquisitions, and Joint Ventures
8.4. Supply - Contract

9. Company Profiles (Introduction, Financials, Key Insights, Key Strategy, Product Portfolio, SWOT Analysis)
9.1. Roche
9.2. Ranbaxy Laboratories Ltd
9.3. Merck KGaA
9.4. Pfizer
9.5. Novartis
9.6. Takeda Pharma
9.7. AstraZeneca
9.8. Johnson & Johnson
9.9. Eli Lilly
9.10. Amgen
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"

10. Appendix
10.1. Abbreviations
10.2. Sources
10.3. Research Methodology
10.4. Expert Insights
Note: Product cover images may vary from those shown
3 of 3


4 of 3
Note: Product cover images may vary from those shown